HTA11 Early Access Programs (EAPs) in France: Reasons for Refusal von Chamoux, C, Outteridge, G

Volltext

Vehicle lightweighting through the use of molybdenum-bearing advanced high-strength steels (AHSS) von Hardwick, Alexander Patrick, Outteridge, Tim

Volltext

Platelet P2Y12 Inhibitors Reduce Systemic Inflammation and Its Prothrombotic Effects in an Experimental Human Model von Thomas, Mark R, Outteridge, Samuel N, Ajjan, Ramzi A, Phoenix, Fladia, Sangha, Gurpreet K, Faulkner, Rachael E, Ecob, Rosemary, Judge, Heather M, Khan, Haroon, West, Laura E, Dockrell, David H, Sabroe, Ian, Storey, Robert F

Volltext

HTA304 Is the New EU HTA Process Fit for Engagement of Patients With Rare Diseases? von Bahar, N, Chamoux, C, Outteridge, G

Volltext

HTA254 Potential Discrepancies/Misalignments in Future EU-HTA Appraisals the POLIVY and Stelara JA3 PICO Example von Berto, P., Chamoux, C., Outteridge, G., Roeder, C.

Volltext

Antivirals for Broader Coverage against Human Coronaviruses von Outteridge, Mia, Nunn, Christine M, Devine, Kevin, Patel, Bhaven, McLean, Gary R

Volltext

PT29 Predicting PICOs for EU Joint Clinical Assessment: Lessons from PICOs in Relative Effectiveness Assessments (REA) from EUnetHTA Joint Action 3 Project von Chamoux, C., Outteridge, G., Berto, P.

Volltext

Editorial: Industrial relevance of molybdenum in China von Outteridge, Tim, Kinsman, Nicole, Ronchi, Gaetano, Mohrbacher, Hardy

Volltext

HPR33 Price Erosion for Haemato-Oncology Drugs in European Markets von Black, RM, Chamoux, C, Outteridge, GJ, Tak, S

Volltext

HTA251 Unraveling the Relationship between Expedited Regulatory Approval By the European Medicines Agency (EMA) and Reimbursement Outcomes for Drugs Approved Under Exceptional Circ... von Guyenet, A., Berto, P., Chamoux, C., Crathorne, L., Outteridge, G., Roeder, C.

Volltext

HTA117 A Targeted Literature Review Into Incorporating Environmental Impact of Healthcare Into Health Technology Assessments (HTAS) von Kiritharakopalan, D, Lister, J, Outteridge, GJ, Patel, C, Ozer Stillman, I

Volltext

PCN181 Real-World Evidence (RWE) in Reimbursement, Pricing, and Health Technology Assessment (HTA) in ASIA. How CAN Rwe Supplement Trial DATA in Oncology Indications in a Premarket... von Schoenherr, N., Brogan, A., Outteridge, G.J., Patel, J., Perez, Zaballos MT, Bobiak, S.

Volltext

Hypoxia Inducible Factor (HIF)‐1 accelerates epithelial wound healing through integrin regulation von Goggins, Bridie Jane, Minahan, Kyra, Outteridge, Noah, Knight, Darryl, Horvat, Jay, Keely, Simon

Volltext

Editorial: Industrial relevance of molybdenum in China von Mohrbacher, Hardy, Outteridge, Tim, Kinsman, Nicole, Ronchi, Gaetano

Volltext

PHP142 - TRENDS AND UTILIZATION OF REAL-WORLD EVIDENCE-BASED INFORMATION TO SUPPORT MARKET ACCESS IN THE UNITED STATES von Kumar, P., Outteridge, G., Meadows, N.

Volltext

COMPARISON OF FACTORS INFLUENCING RECENT REIMBURSEMENT DECISIONS OF ADVANCED NON-SMALL-CELL LUNG CANCER THERAPIES ACROSS LEADING HTA AGENCIES von Kumar, P, Jyothsna, B S, G, G Outteridge

Volltext

TRENDS AND UTILIZATION OF REAL-WORLD EVIDENCE-BASED INFORMATION TO SUPPORT MARKET ACCESS IN THE UNITED STATES von Kumar, P, Outteridge, G, Meadows, N

Volltext

203Ticagrelor and Clopidogrel Attenuate the Prothrombotic State induced by Bacterial Endotoxaemia von Thomas, Mark, Ajjan, Ramzi, Phoenix, Fladia, Outteridge, Samuel, Dockrell, David, Sabroe, Ian, Storey, Robert

Volltext

203 Ticagrelor and Clopidogrel Attenuate the Prothrombotic State induced by Bacterial Endotoxaemia von Thomas, Mark, Ajjan, Ramzi, Phoenix, Fladia, Outteridge, Samuel, Dockrell, David, Sabroe, Ian, Storey, Robert

Volltext

TICAGRELOR INHIBITS CHANGES IN FIBRIN CLOT STRUCTURE INDUCED BY BACTERIAL ENDOTOXEMIA von Thomas, Mark R, Ajjan, Ramzi A, Phoenix, Fladia, Outteridge, Samuel N, Dockrell, David H, Sabroe, Ian, Storey, Robert F

Volltext